Skip to content

Comparative study of the effect of SVF and PRP in the treatment of hereditary hair loss

A comparative study of the effect of SVF and PRP in the treatment of androgenetic alopecia in the patients of Razi Hospital

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20240623062223N1
Enrollment
24
Registered
2024-08-19
Start date
2024-08-10
Completion date
Unknown
Last updated
2024-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

androgenic alopecia. Androgenic alopecia, unspecified

Interventions

Intervention 1: The first intervention group: a group with androgenetic alopecia for whom three injections (0.1 ml/cm2 of SVF) are performed in the scalp at intervals of 0, 3 and 6 months. (The Colema

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Age above 18 years Those who have enough abdominal or subcutaneous fat tissue that is accessible with a syringe Norwood-Hamilton grades II-VI or Ludwig Class I-III• . Active hair loss in the last 12 months• Diagnosis of AGA based on clinical examination and trichoscopy

Exclusion criteria

Exclusion criteria: In case of other treatments for hair loss in the last 3 months • Pregnancy • Simultaneous treatment with other AGA treatments Systemic diseases or scalp diseases that may affect hair growth History of hair transplant

Design outcomes

Primary

MeasureTime frame
Androgenic alopecia score based on Norwood-Hamilton scale or Ludwig scale. Timepoint: Before treatment, 3 months and then 6 months after starting treatment. Method of measurement: In our study «Comparison of the effect of SVF and PRP on increasing the density and thickness of hair», the outcome variable is measured by videotrichoscope and clinical photography.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDelnia Shiri

Tehran University of Medical Sciences

shirydlnia@gmail.com+98 44 4244 0626

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026